Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

Building on their existing collaboration, the companies have signed a new agreement to focus on lead optimization of drug candidates identified by Variational AI’s Enki™ generative AI platform and ...

Kazia Therapeutics (NASDAQ: KZIA) today announced that its Chief Executive Officer, John Friend, MD, will be in San Francisco next week to participate in meetings during the annual J.P. Morgan ...

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...

Z-endoxifen has demonstrated efficacy in phase 1 and 2 trials, improving progression-free survival and tumor response in ...

Diabetes is an ongoing medical condition that affects millions of people across the globe. Blood sugar needs to be controlled ...

Furthermore, GLP-1 drugs had a favorable safety profile versus aspirin, particularly with respect to bleeding events, said ...

Strength gains depend on a delicate balance between muscle protein synthesis and breakdown, that is: the body’s ability to ...

Scientists have uncovered evidence that two defining features of cancer are driven by the same underlying molecular process. These features include ...

Genetic and metabolic differences may increase aggressive early breast cancer risk in Latin American women with obesity, ...

The global cancer drugs market is surging toward $594.3 billion by 2035 as high-tech immunotherapies begin to replace ...